New Euro chief at Cambrex
Cambrex has continued its recruitment of top-level executives in its pharmaceutical and biopharma business unit with the appointment of Edward Robinson as executive vice president for Europe.
Archives for December 2, 2003
Asthma drug will use SkyePharma inhaler tech
A new drug for asthma and chronic obstructive pulmonary disease (COPD), developed by Swiss drugmaker Novartis, will make use of two technologies developed by UK drug delivery firm SkyePharma.
Taking assays to the sub-microlitre level
Over the last few years, researchers involved in high-throughput screening have been seeking out the use of their expensive reagents by developing assays that use smaller and smaller volumes, helped by sophisticated automation technologies.